CMG Pharmaceutical Co., Ltd. 058820.KQ Stock
CMG Pharmaceutical Co., Ltd. Price Chart
CMG Pharmaceutical Co., Ltd. 058820.KQ Financial and Trading Overview
CMG Pharmaceutical Co., Ltd. stock price | 2105 KRW |
Previous Close | 2130 KRW |
Open | 2155 KRW |
Bid | 2135 KRW x 0 |
Ask | 2155 KRW x 0 |
Day's Range | 2125 - 2170 KRW |
52 Week Range | 1900 - 3080 KRW |
Volume | 340.29K KRW |
Avg. Volume | 542.47K KRW |
Market Cap | 231.4B KRW |
Beta (5Y Monthly) | 0.880055 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
058820.KQ Valuation Measures
Enterprise Value | 201.5B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.8537724 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 3.356 |
Enterprise Value/EBITDA | 42.661 |
Trading Information
CMG Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.880055 |
52-Week Change | -19.92% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3080 KRW |
52 Week Low | 1900 KRW |
50-Day Moving Average | 2227.2 KRW |
200-Day Moving Average | 2249.03 KRW |
058820.KQ Share Statistics
Avg. Volume (3 month) | 542.47K KRW |
Avg. Daily Volume (10-Days) | 338.38K KRW |
Shares Outstanding | 108.89M |
Float | 102.99M |
Short Ratio | N/A |
% Held by Insiders | 25.84% |
% Held by Institutions | 4.01% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2019 |
Most Recent Quarter (mrq) | March 31, 2020 |
Next Fiscal Year End | December 31, 2020 |
Profitability
Profit Margin | 6.23% |
Operating Margin (ttm) | 4.09% |
Gross Margin | 49.86% |
EBITDA Margin | 7.86% |
Management Effectiveness
Return on Assets (ttm) | 0.98% |
Return on Equity (ttm) | 2.61% |
Income Statement
Revenue (ttm) | 60.04B KRW |
Revenue Per Share (ttm) | 481.46 KRW |
Quarterly Revenue Growth (yoy) | 10.80% |
Gross Profit (ttm) | 28.89B KRW |
EBITDA | 4.72B KRW |
Net Income Avi to Common (ttm) | 3.74B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 131.50% |
Balance Sheet
Total Cash (mrq) | 116.69B KRW |
Total Cash Per Share (mrq) | 840.15 KRW |
Total Debt (mrq) | 817.86M KRW |
Total Debt/Equity (mrq) | 0.45 KRW |
Current Ratio (mrq) | 13.424 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.92B KRW |
Levered Free Cash Flow (ttm) | 13.23B KRW |
Profile of CMG Pharmaceutical Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | Cheongdam-dong 18-20, #B01 |
ZIP | 135-949 |
Phone | 82 3 1881 7600 |
Website | https://www.cmgpharma.co.kr |
Industry | |
Sector(s) | |
Full Time Employees | N/A |
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.
Q&A For CMG Pharmaceutical Co., Ltd. Stock
What is a current 058820.KQ stock price?
CMG Pharmaceutical Co., Ltd. 058820.KQ stock price today per share is 2105 KRW.
How to purchase CMG Pharmaceutical Co., Ltd. stock?
You can buy 058820.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CMG Pharmaceutical Co., Ltd.?
The stock symbol or ticker of CMG Pharmaceutical Co., Ltd. is 058820.KQ.
How many shares does CMG Pharmaceutical Co., Ltd. have in circulation?
The max supply of CMG Pharmaceutical Co., Ltd. shares is 138.89M.
What is CMG Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
CMG Pharmaceutical Co., Ltd. PE Ratio is now.
What was CMG Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
CMG Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.